Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Recent Registrations
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
January
-
February
-
March
-
April
-
May
-
June
-
July
-
August
-
September
-
Oktober
- November -
December
|
2002
-
2003
-
2004
-
2005
-
2006
-
2007
- 2008 -
2009
-
2010
-
2011
-
2012
-
2013
-
2014
-
2015
-
2016
-
2017
-
2018
-
2019
-
2020
-
2021
-
2022
-
2023
-
2024
-
2025
November 2008 - 25 products
L
IP
CI
Volibris 5 mg
30 Tablet(s)
1089.60
1195.35
10 %
Coated tablets: Ambrisentanum 5 mg
GlaxoSmithKline AG
B / SL / SO
FB
G
L
IP
CI
Volibris 10 mg
30 Tablet(s)
1089.60
1195.35
10 %
Coated tablets: Ambrisentanum 10 mg
GlaxoSmithKline AG
B / SL / SO
FB
G
IP
CI
Tamsulosin-Mepha retard
10
4.59
14.25
10 %
Delayed release capsules: Tamsulosini Hydrochloridum
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
Tamsulosin-Mepha retard
30
10.29
27.60
10 %
Delayed release capsules: Tamsulosini Hydrochloridum
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
Tamsulosin-Mepha retard
100
33.06
52.35
10 %
Delayed release capsules: Tamsulosini Hydrochloridum
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
CI
Doxazosin retard Zentiva 4 mg
28
8.92
26.10
10 %
Coated tablets: Doxazosinum 4 mg
Helvepharm AG
B / SL / SG
FB
G
L
IP
CI
Doxazosin retard Zentiva 4 mg
98
29.08
48.05
10 %
Coated tablets: Doxazosinum 4 mg
Helvepharm AG
B / SL / SG
FB
G
L
IP
CI
Doxazosin retard Zentiva 8 mg
28
11.58
29.00
10 %
Coated tablets: Doxazosinum 8 mg
Helvepharm AG
B / SL / SG
FB
G
L
IP
CI
Doxazosin retard Zentiva 8 mg
98
42.59
62.75
10 %
Coated tablets: Doxazosinum 8 mg
Helvepharm AG
B / SL / SG
FB
G
IP
CI
Sumatriptan-Mepha
6
16.89
34.80
10 %
Coated tablets: Sumatriptanum 50 mg
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
Sumatriptan-Mepha
12
33.62
53.00
10 %
Coated tablets: Sumatriptanum 50 mg
Mepha Pharma AG
● 
B / SL / SG
FB
G
L
IP
CI
Natulan
50 Capsule(s)
241.70
279.30
10 %
capsule rigide: Procarbazinum 50 mg
CD PHARMA (SUISSE) SA
A / SL
FB
G
IP
KCL 7,45% Sintetica,
concentrato per soluzione per
infusione (fiala di 50 ml)
ampoule(s) à 50 ml
PR
PR
k.A.
Concentrate for infusion: 2 Active Agents
Sintetica SA
B
FB
G
IP
KCL 7,45% Sintetica,
concentrato per soluzione per
infusione (fiala di 50 ml)
10 1 ampoule(s) à 50 ml
PR
PR
k.A.
Concentrate for infusion: 2 Active Agents
Sintetica SA
B
FB
G
IP
CI
Tamsulosin-Mepha retard
20
PR
PR
k.A.
Delayed release capsules: Tamsulosini Hydrochloridum
Mepha Pharma AG
B
FB
G
IP
CI
Tamsulosin-Mepha retard
50
PR
PR
k.A.
Delayed release capsules: Tamsulosini Hydrochloridum
Mepha Pharma AG
B
FB
G
IP
CI
Tamsulosin-Mepha retard
60
PR
PR
k.A.
Delayed release capsules: Tamsulosini Hydrochloridum
Mepha Pharma AG
B
FB
G
IP
CI
Tamsulosin-Mepha retard
90
PR
PR
k.A.
Delayed release capsules: Tamsulosini Hydrochloridum
Mepha Pharma AG
B
FB
G
IP
CI
Tamsulosin-Mepha retard
200
PR
PR
k.A.
Delayed release capsules: Tamsulosini Hydrochloridum
Mepha Pharma AG
B
FB
G
IP
CI
Cetirizin Stada
10
PR
PR
k.A.
Tablets: Cetirizini Dihydrochloridum 10 mg
Spirig HealthCare AG
D
FB
G
IP
CI
Cetirizin Stada
30
PR
PR
k.A.
Tablets: Cetirizini Dihydrochloridum 10 mg
Spirig HealthCare AG
D
FB
G
IP
CI
Cetirizin Stada
50
PR
PR
k.A.
Tablets: Cetirizini Dihydrochloridum 10 mg
Spirig HealthCare AG
D
FB
G
CI
H
Similasan Beruhigung
60 Tablet(s)
PR
PR
k.A.
Tablets: 4 Active Agents
Similasan AG
D
FB
G
IP
KCL 7,45% Sintetica
ampoule(s) à 20 ml
PR
PR
k.A.
concentrato per soluzione per infusione: Kalii Chloridum 74.5 mg/ml
Sintetica SA
B
FB
G
IP
KCL 7,45% Sintetica
10 1 ampoule(s) à 20 ml
PR
PR
k.A.
concentrato per soluzione per infusione: Kalii Chloridum 74.5 mg/ml
Sintetica SA
B
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home